CLINICAL_TRIALS
trial_result
· 2020-07-09
Clinical Trial Update: A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor [Phase 2]
Summary
Phase 2 trial of pembrolizumab in thymic epithelial tumors has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Samsung Medical Center | Conditions: Thymic Epithelial Tumors | Phase 2 | Status: COMPLETED